Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Humanin
100%
Growth Factors
22%
Insulin-like
22%
Insulin Sensitivity
14%
Diabetes Prevention Program
14%
Diabetes Risk
7%
Mitochondrial-derived Peptides
7%
Human Plasma
7%
Increasing Age
7%
Insulin-like Growth Factor Binding protein-3 (IGFBP-3)
7%
Lifestyle Modification
7%
Hepatic Glucose Production
7%
Blood Samples
7%
Diabetes
7%
Binding Protein
7%
Diabetes Outcomes
7%
Placebo
7%
Ancillary
7%
Glucose Uptake
7%
ELISA Assay
7%
Nested Case-control Study
7%
Metformin Therapy
7%
Blood Glucose
7%
Central Administration
7%
Central Effects
7%
Impaired Glucose Tolerance
7%
Stored Blood
7%
Alzheimer's Disease
7%
Insulin Action
7%
Insulin Secretion
7%
Glucose Metabolism
7%
Incident Diabetes
7%
Peripheral Administration
7%
Highly Sensitive
7%
Large Sample Size
7%
Novel Biomarkers
7%
Mitochondrial DNA
7%
Circulating Levels
7%
Age-related Illnesses
7%
Disease-related Proteins
7%
High Risk of Diabetes
7%
Alzheime's Disease
7%
Potential Biomarkers
7%
Pharmacology, Toxicology and Pharmaceutical Science
Humanin
100%
Maturity Onset Diabetes of the Young
100%
Glucose
29%
Biological Marker
22%
Insulin
22%
Somatomedin
14%
Diseases
9%
Binding Protein
7%
Metformin
7%
Enzyme-Linked Immunosorbent Assay
7%
Alzheimer's Disease
7%
Pathophysiology
7%
Impaired Glucose Tolerance
7%
Mitochondrial DNA
7%
Somatomedin C
7%
Placebo
7%
Obesity
7%
Peptide
7%
Neuroscience
Humanin
100%
Insulin
22%
Biological Marker
22%
Glucose
22%
Somatomedin
14%
Blood Plasma
7%
Gluconeogenesis
7%
ELISA
7%
Protein Binding
7%
Mitochondrial DNA
7%
Metabolic Pathway
7%
Metformin
7%
Placebo
7%
Peptide
7%
Alzheimer's Disease
7%
Glucose Transport
7%
Insulin-Like Growth Factor 1
7%